Emerging in vitro models to study Merkel cell carcinoma pathobiology

Chiara Mazziotta1, John Charles Rotondo2

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.

Summary

Merkel cell carcinoma (MCC) research requires better preclinical models. This review details current 2D and 3D in vitro models for studying MCC development and progression, aiding future clinical applications.

Related Concept Videos